(Press-News.org) For the past decade, scientists have been pursuing cancer treatments based on RNA interference — a phenomenon that offers a way to shut off malfunctioning genes with short snippets of RNA. However, one huge challenge remains: finding a way to efficiently deliver the RNA.
Most of the time, short interfering RNA (siRNA) — the type used for RNA interference — is quickly broken down inside the body by enzymes that defend against infection by RNA viruses.
"It's been a real struggle to try to design a delivery system that allows us to administer siRNA, especially if you want to target it to a specific part of the body," says Paula Hammond, the David H. Koch Professor in Engineering at MIT.
Hammond and her colleagues have now come up with a novel delivery vehicle in which RNA is packed into microspheres so dense that they withstand degradation until they reach their destinations. The new system, described Feb. 26 in the journal Nature Materials, knocks down expression of specific genes as effectively as existing delivery methods, but with a much smaller dose of particles.
Such particles could offer a new way to treat not only cancer, but also any other chronic disease caused by a "misbehaving gene," says Hammond, who is also a member of MIT's David H. Koch Institute for Integrative Cancer Research. "RNA interference holds a huge amount of promise for a number of disorders, one of which is cancer, but also neurological disorders and immune disorders," she says.
Lead author of the paper is Jong Bum Lee, a former postdoc in Hammond's lab. Postdoc Jinkee Hong, Daniel Bonner PhD '12 and Zhiyong Poon PhD '11 are also authors of the paper.
Genetic disruption
RNA interference is a naturally occurring process, discovered in 1998, that allows cells to fine-tune their genetic expression. Genetic information is normally carried from DNA in the nucleus to ribosomes, cellular structures where proteins are made. siRNA binds to the messenger RNA that carries this genetic information, destroying instructions before they reach the ribosome.
Scientists are working on many ways to artificially replicate this process to target specific genes, including packaging siRNA into nanoparticles made of lipids or inorganic materials such as gold. Though many of those have shown some success, one drawback is that it's difficult to load large amounts of siRNA onto those carriers, because the short strands do not pack tightly.
To overcome this, Hammond's team decided to package the RNA as one long strand that would fold into a tiny, compact sphere. The researchers used an RNA synthesis method known as rolling circle transcription to produce extremely long strands of RNA made up of a repeating sequence of 21 nucleotides. Those segments are separated by a shorter stretch that is recognized by the enzyme Dicer, which chops RNA wherever it encounters that sequence.
As the RNA strand is synthesized, it folds into sheets that then self-assemble into a very dense, sponge-like sphere. Up to half a million copies of the same RNA sequence can be packed into a sphere with a diameter of just two microns. Once the spheres form, the researchers wrap them in a layer of positively charged polymer, which induces the spheres to pack even more tightly (down to a 200-nanometer diameter) and also helps them to enter cells.
After the spheres enter a cell, the Dicer enzyme chops the RNA at specific locations, releasing the 21-nucleotide siRNA sequences.
Targeting tumors
In the Nature Materials paper, the researchers tested their spheres by programming them to deliver RNA sequences that shut off a gene that causes tumor cells to glow in mice. They found that they could achieve the same level of gene knockdown as conventional nanoparticle delivery, but with about one-thousandth as many particles.
The microsponges accumulate at tumor sites through a phenomenon often used to deliver nanoparticles: The blood vessels surrounding tumors are "leaky," meaning that they have tiny pores through which very small particles can squeeze.
In future studies, the researchers plan to design microspheres coated with polymers that specifically target tumor cells or other diseased cells. They are also working on spheres that carry DNA, for potential use in gene therapy.
INFORMATION:
Written by Anne Trafton, MIT News
END
PASADENA, Calif.—Bacteria have evolved different systems for secreting proteins into the fluid around them or into other cells. Some, for example, have syringe-like exterior structures that can pierce other cells and inject proteins. Another system, called a type VI secretion system, is found in about a quarter of all bacteria with two membranes. Despite being common, researchers have not understood how it works. Now a team, co-led by researchers at the California Institute of Technology (Caltech), has figured out the structure of the type VI secretion system apparatus ...
ZyLAB, a leading provider of eDiscovery and information management solutions, today announced that it has been named to KMWorld Magazine's prestigious list of the "100 Companies that Matter in Knowledge Management." Published annually and in its 12th year, this list recognizes organizations that play a role in the creation and evolution of the knowledge management market through consistent innovation of technologies, products and services. Companies chosen for this list are compiled by KM practitioners, theorists, analysts, vendors and their customers and colleagues. ...
People who take Ritalin are far more aware of their mistakes, a University of Melbourne study has found.
The study, by Dr Rob Hester from the Department of Psychological Sciences and colleagues at the Queensland Brain Institute, investigated how the brain monitors ongoing behaviour for performance errors – specifically failures of impulse control.
It found that a single dose of methylphenidate (Ritalin) results in significantly greater activity in the brain's error monitoring network and improved volunteers' awareness of their mistakes.
Diminished awareness of performance ...
An irregular heartbeat — atrial fibrillation — is a strong predictor of cognitive decline and the loss of independence in daily activities in older people at risk of cardiovascular disease, according to a study in CMAJ (Canadian Medical Association Journal).
Researchers sought to understand whether there was an association between an irregular heartbeat and the loss of mental and physical functions in people at risk of cardiovascular disease. They looked at data from two randomized controlled trials: the ONTARGET and TRANSCEND trials, which involved 31 506 patients from ...
A new study has found that patients with chronic myeloid leukemia (CML) who have not responded to interferon treatments experience long-term benefits when they switch to the targeted drug imatinib. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that imatinib is the treatment of choice for these patients.
Imatinib, a drug that blocks the protein made by a particular cancer-causing gene, has revolutionized the treatment and prognosis of patients with CML. Now up to 93 percent of patients who take the drug as ...
PASADENA, Calif., (February 27, 2012) – Children and adolescents who are overweight or obese are more likely to have asthma than their healthy weight counterparts, according to a new Kaiser Permanente Southern California study published in the online edition of Obesity. The study, which included more than 681,000 children between ages 6 and 19, found that the association between asthma and body mass index varied by race and ethnicity.
The study found that the association between BMI and asthma was weaker for African Americans, a group that was previously known to have ...
Millions of adults suffer from the incurable disease multiple sclerosis (MS). It is relatively certain that MS is an autoimmune disease in which the body's own defense cells attack the myelin in the brain and spinal cord. Myelin enwraps the nerve cells and is important for their function of transmitting stimuli as electrical signals. There are numerous unconfirmed hypotheses on the development of MS, one of which has now been refuted by the neuroimmunologists in their current research: The death of oligodendrocytes, as the cells that produce the myelin sheath are called, ...
Mathematically, is it possible to continuously deform a rough sphere into a perfect sphere? Under what situations can we solve the differential equations?
Professor Xu Xingwang of the Department of Mathematics at National University of Singapore (NUS), along with Dr Chen Xuezhang from Nanjing University of China, has established a new method to tackle this long-standing problem.
What it used to be
Of the various different ways to measure the roughness of the sphere, the scalar curvature measurement has proven to be the weakest one, resulting in a problem commonly known ...
Web applications such as Google Mail, Facebook and Amazon are used every day. However, so far there are no methods to test them systematically and at low cost for malfunctions and security vulnerabilities. Therefore, computer scientists from Saarland University are working on automatic methods of testing, which check complex web applications autonomously. For the first time, they will present this work at exhibition booth F34 in hall 26 at the computer fair Cebit. The trade show will take place from March 6 to 10 in Hannover.
"Ineffective and inefficient" is Valentin ...
People like to keep a safe distance from explosive substances, but in order to analyze them, close contact is usually inevitable. At the Vienna University of Technology, a new method has now been developed to detect chemicals inside a container over a distance of more than a hundred meters. Laser light is scattered in a very specific way by different substances. Using this light, the contents of a nontransparent container can be analyzed without opening it.
Scattered Light as a "Chemical Fingerprint"
"The method we are using is Raman-spectroscopy", says Professor Bernhard ...
